Main Menu

Research overview

Professor Richard Houlston, Cancer Genomics team

The Houlston Group has a primary interest in using genetic approaches to understand a genetic background underlying susceptibility and pathogenesis of human malignancies.

The research of the group focuses on the following strands:

  • Susceptibility gene identification in cancer using large-scale genetic and genomic approaches. We are involved in the major international efforts exploiting large-scale genome wide association and next-generation sequencing efforts to map variants impacting on cancer predisposition
  • Translating gene identification into biological insights and clinical advances. We use complementary approaches involving human, animal models and cellular systems to define the biological and clinical consequences of discoveries.
  • Genomic epidemiology. Integrating genetic and other data to advance understanding of basic genomic processes.
  • Statistical genetics and bioinformatics. Implementation of new approaches to tackle associated analytical challenges.
  • Our recent research has made a major contribution to advances in the understanding of the genetic basis of cancer and our work has featured in over 50 papers published in Nature Genetics, Nature and Science.

In this section

Research overview Publications